Evidence map›Paper›PMID 9755165›Full record

ArticleThe EMBO journal1998

A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.

D Yablonski, L P Kane, D Qian, A Weiss

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Article
  3. Wiskott-Aldrich Syndrome Protein: Roles in Signal Transduction in T Cells.Frontiers in cell and developmental biology · 2021
    Review
  4. Sinner or Saint?: Nck Adaptor Proteins in Vascular Biology.Frontiers in cell and developmental biology · 2021
    Review
  5. Review
  6. Article
  7. Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  8. Article
  9. Induced transcription and stability of CELF2 mRNA drives widespread alternative splicing during T-cell signaling.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D YablonskiDepartments of Medicine, Microbiology and Immunology and the Howard Hughes Medical Institute, University of California, San Francisco, California 94143-0795, USA.
L P Kane
D Qian
A Weiss
Howard Hughes Medical Institute · US

Funding

FUNCTION OF THE VAV PROTOONCOGENER01CA072531 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WEISS, ARTHUR · 1997 to 2004
$1.2M
NCI NIH HHS R01 1CA72531
6 · The paper itself

Abstract

The T-cell antigen receptor (TCR) triggers a signaling cascade initiated by the tyrosine kinase Lck and requiring the proto-oncogene p95(vav). Vav is activated by Lck and can function as a guanine nucleotide exchange factor for the Rho-family GTPases, Rac1 and Cdc42. To investigate the involvement of these GTPases in TCR signaling, we focused on their well characterized effector, Pak1. This serine/threonine kinase is activated by GTP-bound Rac1 or Cdc42. However, its role in mediating downstream signaling events is controversial. We observed rapid, TCR-dependent activation of Pak1 and TCR-inducible association of Pak1 with Nck, which was tyrosine phosphorylated following stimulation. Pak1 activation occurred independently of Ras activation or calcium flux, but was dependent on the Lck tyrosine kinase, and was downstream of Vav and Cdc42. Dominant negative Pak1 or Nck specifically inhibited TCR-mediated activation of the nuclear factor of activated T cells (NFAT) transcription factor. TCR-mediated activation of Erk2 was also inhibited by dominant negative Pak. However, Pak1 activation was neither necessary nor sufficient for TCR-dependent c-Jun N-terminal kinase (JNK) activation. Therefore, Pak1 acts downstream of Vav and is required for activation of Erk2 and NFAT by a JNK-independent pathway. This is the first demonstration of a requirement for Pak to mediate the regulation of gene expression by an extracellular ligand.

Indexed as

Mitogen-Activated Protein KinasesNuclear ProteinsAdaptor Proteins, Signal TransducingCalcium-Calmodulin-Dependent Protein KinasesDNA-Binding ProteinsEnzyme ActivationGene Expression RegulationGTP-Binding ProteinsHumansJNK Mitogen-Activated Protein KinasesJurkat CellsLymphocyte Specific Protein Tyrosine Kinase p56(lck)NFATC Transcription FactorsOncogene Proteinsp21-Activated KinasesProtein Serine-Threonine KinasesAdaptor Proteins, Signal TransducingCalcium-Calmodulin-Dependent Protein KinasesDNA-Binding ProteinsGTP-Binding ProteinsJNK Mitogen-Activated Protein KinasesLymphocyte Specific Protein Tyrosine Kinase p56(lck)MAS1 protein, humanMitogen-Activated Protein KinasesNck proteinNFATC Transcription FactorsNuclear ProteinsOncogene Proteinsp21-Activated KinasesPAK1 protein, humanProtein Serine-Threonine KinasesProto-Oncogene MasReceptors, Antigen, T-CellTranscription Factors

Identifiers

PMID9755165
PMCPMC1170893
OpenAlexW2017078845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.